{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:22:48Z","timestamp":1792873368889,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/aog.0b013e3181626d1b","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:40:23Z","timestamp":1291102823000},"page":"278-284","source":"Crossref","is-referenced-by-count":63,"title":["Effects of Oral and Transdermal Hormonal Contraception on Vascular Risk Markers"],"prefix":"10.1097","volume":"111","author":[{"given":"Julia V.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Badger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Tchaikovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210126","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis.","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-5-20210126","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrin Metab"},{"key":"R3-5-20210126","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"R4-5-20210126","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1210\/jcem.86.3.7297","article-title":"The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.","volume":"86","author":"Perera","year":"2001","journal-title":"J Clin Endocrin Metab"},{"key":"R5-5-20210126","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein\u2014a cross-sectional population survey.","volume":"86","author":"Lowe","year":"2001","journal-title":"Thromb Haemost"},{"key":"R6-5-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 mcg of ethinyl estradiol.","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R7-5-20210126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R8-5-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0010-7824(78)90012-4","article-title":"Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.","volume":"17","author":"Humpel","year":"1978","journal-title":"Contraception"},{"key":"R9-5-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"R10-5-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"R11-5-20210126","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00044-X","article-title":"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables.","volume":"59","year":"1999","journal-title":"Contraception"},{"key":"R12-5-20210126","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0002-9378(99)70366-2","article-title":"The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.","volume":"181","author":"Archer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R13-5-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias, and risk of venous thromboembolism: a systematic review. The Thrombosis, Risk, and Economic Assessment of Thrombophilia Screening (TREATS) Study.","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"R14-5-20210126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"R15-5-20210126","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9378(97)70289-8","article-title":"Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.","volume":"177","author":"Vandenbroucke","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R16-5-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","article-title":"Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response.","volume":"4","author":"van Rooijen","year":"2006","journal-title":"J Thrombos Haemost"},{"key":"R17-5-20210126","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.0306-5251.2001.01532.x","article-title":"Pharmacokinetics of a contraceptive patch (Evra and Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.","volume":"53","author":"Abrams","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R18-5-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma.","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R19-5-20210126","article-title":"Design and analysis of cross-over trials. 2nd ed.","author":"Jones","year":"2003"},{"key":"R20-5-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCULATIONAHA.104.504159","article-title":"C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.","volume":"112","author":"Cushman","year":"2005","journal-title":"Circulation"},{"key":"R21-5-20210126","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomized cross-over study.","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"R22-5-20210126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial.","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200802000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:43:50Z","timestamp":1786041830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200802000-00005"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181626d1b","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}